CMC Pharmaceuticals Awarded Sequential Phase II SBIR Grant to Continue Pharmaceutical Development of a Medical Countermeasure to Nerve Agents Solon, OH: CMC Pharmaceuticals has been awarded a Sequential Phase II Small Business Innovation Research (“SBIR”) grant from the U.S. Defense Department’s (“DoD”) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), […]
PODD: Partnership Opportunities in Drug Delivery – 2022 Conference Recap
After a long couple of years and many virtual conferences, the team at CMC Pharma is back on the road. Mid-2022 we took a trip up north to Montreal for the Controlled Release Society’s Annual meeting. Then, this October, we traveled to the PODD (Partnership Opportunities in Drug Delivery) Conference in Boston. It was great […]
The Importance of Stability Studies in Pharmaceuticals
The Importance of Stability Studies in Pharmaceuticals Stability studies in pharmaceuticals are performed from early development through regulatory approval and commercialization. Understanding the stability and shelf-life of a pharmaceutical drug product (DP, or Finished dosage form) and drug substance (DS or active pharmaceutical ingredient, API) is a critical quality component to ensure the safety and […]
CMC Pharmaceuticals Expands Chemical Defense Portfolio
Department of Defense Awards CMC Pharma SBIR Grant, Adding to Existing Chemical Defense Portfolio Solon, OH: The Department of Defense’s (DoD) Chemical and Biological Defense (CBD) Small Business Innovation Research (SBIR) program awarded CMC Pharmaceuticals an SBIR contract managed by the DoD’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) […]
CMC Pharmaceuticals Awarded SBIR Grant For Concentrated Atropine Formulation
CMC Pharmaceuticals Awarded SBIR Grant For Concentrated Atropine Formulation Solon, OH: CMC Pharmaceuticals has been awarded a Small Business Innovation (SBIR) grant from U.S. Special Operations Command (SOCOM). The Phase I SBIR award will fund the formulation and analytical development of a concentrated Atropine Sulfate Drug Product. The application of this new formulation aims to aid […]
CMC Pharmaceuticals Announces Collaborative Partnership
New Agreement with Federal Equipment Company Expands Companies Capabilities Solon, OH: CMC Pharmaceuticals, a provider of drug product development services to the pharmaceutical and biotech industries, announces a collaborative partnership with Federal Equipment Company (“FEC”). FEC is a dealer of industrial processing equipment with a focus on pharmaceutical and chemical manufacturing. This agreement grants CMC […]
CMC Pharmaceuticals Announces New Advisory Board
CMC Pharmaceuticals Announces New Advisory Board Solon, OH: CMC Pharmaceuticals, a provider of drug product development services to the pharmaceutical and biotechnology industries, announces the formation of an Advisory Board. The group of distinguished leaders will advise CMC Pharma on continued growth with a focus on cutting-edge science, business strategy, marketing, and risk reduction. […]
